Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial

BACKGROUND: This study evaluated the effects of aclidinium bromide, a long-acting muscarinic antagonist indicated for maintenance treatment of chronic obstructive pulmonary disease (COPD), on exercise endurance, dyspnea, lung hyperinflation, and physical activity. METHODS: In this randomized, double...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Pulm Med
Auteurs principaux: Beeh, Kai M, Watz, Henrik, Puente-Maestu, Luis, de Teresa, Luis, Jarreta, Diana, Caracta, Cynthia, Gil, Esther Garcia, Magnussen, Helgo
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4364572/
https://ncbi.nlm.nih.gov/pubmed/25539654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-14-209
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires